Caplin Point Laboratories Profile
Key Indicators
- Authorised Capital ₹ 17.00 Cr
- Paid Up Capital ₹ 15.20 Cr
- Company Age 34 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 57.70 Cr
- Satisfied Charges ₹ 45.32 Cr
- Revenue Growth 16.62%
- Profit Growth 20.26%
- Ebitda 2.66%
- Net Worth 22.67%
- Total Assets 22.43%
About Caplin Point Laboratories
Caplin Point Laboratories Limited (CPLL) is a leading Public Limited Indian Non-Government Company incorporated in India on 16 April 1990 and has a history of 34 years and nine months. Its registered office is in Kanchipuram, Tamil Nadu, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524742 and on the National Stock Exchange(NSE) under CAPLIPOINT.
The Corporate was formerly known as Caplin Point Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 17.00 Cr and a paid-up capital of Rs 15.20 Cr.
The company currently has active open charges totaling ₹57.70 Cr. The company has closed loans amounting to ₹45.32 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Caplin Point Laboratories Limited India are Desikachari Muralidharan as CFO and Venkatram Subramanian as Company Secretary. Ranganathan Vijayaraghavan, Paarthipan Chellappan, Deenadayalan Singaram, and Three other members serve as directors at the Company.
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L24231TN1990PLC019053
- Company No.
019053
- Stock Symbol
BSE : 524742 NSE : CAPLIPOINT
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Apr 1990
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Caplin Point Laboratories?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sridhar Ganesan  | Managing Director | 12-Feb-2014 | Current |
| Desikachari Muralidharan | CFO | 19-Feb-2016 | Current |
| Venkatram Subramanian | Company Secretary | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Deenadayalan Singaram | Director | 29-Sep-2022 | Current |
| Ranganathan Vijayaraghavan | Director | 30-Sep-2024 | Current |
| Paarthipan Chellappan | Director | 01-Oct-1993 | Current |
| Gariyali Chanderkanta | Director | 04-Mar-2020 | Current |
| Ramachandramurthy Nagendran | Director | 29-Sep-2022 | Current |
Financial Performance of Caplin Point Laboratories.
Caplin Point Laboratories Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.62% increase. The company also saw a substantial improvement in profitability, with a 20.26% increase in profit. The company's net worth Soared by an impressive increase of 22.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Caplin Point Laboratories?
In 2023, Caplin Point Laboratories had a promoter holding of 70.66% and a public holding of 29.33%. The company had 2 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ashvich Properties Private LimitedPaarthipan Chellappan is a mutual person
Simpson And Company LimitedRanganathan Vijayaraghavan is a mutual person
Sundram Fasteners LimitedRanganathan Vijayaraghavan is a mutual person
Lucas Indian Service LimitedRanganathan Vijayaraghavan is a mutual person
Caplin Steriles LimitedPaarthipan Chellappan, Sridhar Ganesan and 1 more are mutual person
Charges (Loans)
₹57.70 Cr
₹45.32 Cr
Charges Breakdown by Lending Institutions
- The Catholic Syrian Bank Ltd : 40.00 Cr
- Others : 17.60 Cr
- Indian Overseas Bank : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 May 2024 | Others | ₹7.60 Cr | Open |
| 28 Apr 2023 | Others | ₹10.00 Cr | Open |
| 07 May 2007 | The Catholic Syrian Bank Ltd | ₹40.00 Cr | Open |
| 21 Jan 1994 | Indian Overseas Bank | ₹1.00 M | Open |
| 30 Nov 2021 | Others | ₹7.60 Cr | Satisfied |
How Many Employees Work at Caplin Point Laboratories?
Caplin Point Laboratories has a workforce of 875 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Caplin Point Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Caplin Point Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
